Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53

被引:109
作者
Tikoo, Kulbhushan [1 ]
Tripathi, Durga Nand [1 ]
Kabra, Dhiraj G. [1 ]
Sharma, Vikram [1 ]
Gaikwad, Anil Bhanudas [1 ]
机构
[1] NIPER, Dept Pharmacol & Toxicol, Lab Chromatin Biol, Sector 67, SAS Nagar 160062, Punjab, India
关键词
intermittent fasting; calorie restriction; dietary restriction; diabetic nephropathy; oxidative stress; p53; Sir2;
D O I
10.1016/j.febslet.2007.02.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic nephropathy (DN) is one of the main causes of end stage renal disease (ESRD) and a leading cause of diabetes mellitus related morbidity and mortality. Recently, sirtuin are reported to have emerging pathogenetic roles in cancer, muscle differentiation, heart failure, neurodegeneration, diabetes and aging. The aim of the present study was to study the role of intermittent fasting (IF) on DN and studying the expression of Sir2 and p53. At biochemical level, we found that IF causes significant improvement in blood urea nitrogen (BUN), creatinine, albumin and HDL cholesterol, parameters that are associated with the development of DN. Diabetic rats on IF also show significant improvement in onset of hypertension. Interestingly, the expression of Sir2, a NAD dependent histone deacetylase, decreases in diabetic rat kidney and this decrease is overcome by IF. Moreover, we provide evidence for involvement of mitogen activated protein kinases (MAPK) cascade in mediating the effects of IF as there is reduction in the expression of p38 which gets induced under diabetic condition. This was further accompanied by the concomitant decrease in cleavage of caspase3 and p53 expression. These findings suggest that IF significantly improves biochemical parameters associated with development of DN and changes the expression of Sir2 and p53. (c) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1071 / 1078
页数:8
相关论文
共 53 条
[1]   Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy [J].
Adhikary, L ;
Chow, F ;
Nikolic-Paterson, DJ ;
Stambe, C ;
Dowling, J ;
Atkins, RC ;
Tesch, GH .
DIABETOLOGIA, 2004, 47 (07) :1210-1222
[2]  
Allcock GH, 1999, J AM SOC NEPHROL, V10, P2283
[3]   Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake [J].
Anson, RM ;
Guo, ZH ;
de Cabo, R ;
Iyun, T ;
Rios, M ;
Hagepanos, A ;
Ingram, DK ;
Lane, MA ;
Mattson, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6216-6220
[4]   AT1 receptors and L-type calcium channels:: functional coupling in supersensitivity to angiotensin II in diabetic rats [J].
Arun, KHS ;
Kaul, CL ;
Ramarao, P .
CARDIOVASCULAR RESEARCH, 2005, 65 (02) :374-386
[5]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[6]  
CHENG B, 1992, J NEUROSCI, V12, P1558
[7]   Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice [J].
Cheng, HL ;
Mostoslavsky, R ;
Saito, S ;
Manis, JP ;
Gu, YS ;
Patel, P ;
Bronson, R ;
Appella, E ;
Alt, FW ;
Chua, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :10794-10799
[8]   Pathophysiology of diabetic nephropathy [J].
Cooper, ME ;
Gilbert, RE ;
Epstein, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (12) :3-6
[9]   EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ROS-induced renal cell death [J].
Dong, J ;
Ramachandiran, S ;
Tikoo, K ;
Jia, Z ;
Lau, SS ;
Monks, TJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (05) :F1049-F1058
[10]   Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice [J].
Duan, WZ ;
Guo, ZH ;
Mattson, MP .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (02) :619-626